drugset / Trial / NCT07594522
A Study of Ivonescimab in People With Non-Small Cell Lung Cancer
NaSingle-groupOpen-labelTreatment
Summary
The researchers are doing this study to find out whether ivonescimab after receiving standard stereotactic body radiotherapy (SBRT) is an effective treatment in people with Non-Small Cell Lung Cancer (NSCLC).
Timeline
- Start
- 2026-05-12
- Primary completion
- 2028-05-12
- Completion
- 2028-05-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ivonescimab | Monoclonal antibody | — | Intravenous |